vomiting

News

The FDA has delivered some end-of-year cheer to Vanda Pharma after approving Nereus, its drug for the prevention of motion sickness.

News

Japanese pharma also hands back rights to painkiller to US biotech.

News

uniQure's latest data drop for its gene therapy for Huntington's disease, under review in the US and UK, has spooked investors.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.